Vinge advises Vostok New Ventures Ltd in connection with its in kind acquisition of BlaBlaCar

Vinge has advised Vostok New Ventures Ltd (”Vostok”) in connection with an investment in the Paris based ride-sharing service Comuto SA (”BlaBlaCar”).

Vinge advises Bridgepoint in conjunction with its investment in Vitamin Well

Vinge has advised Bridgepoint Development Capital in conjunction with its investment in Vitamin Well AB. Vitamin Well AB is a leading Nordic company within functional drinks, which develops, markets and sells high-quality drinks under the well-known trademarks Vitamin Well, Vitamin Well Free, NOBE aloe vera, NOCCO and the sports drink Vitamin Well+.

Vinge advised Investor in connection with the IPO of Alligator

Vinge advises Perusa in connection with offer on Dialect

Vinge advises Carnegie and Nordea in connection with the listing of Volati on Nasdaq Stockholm

Vinge has assisted Enea AB (publ) in the acquisition of Qosmos S.A.

Vinge advises Daikin and AAF Lufttechnik GmbH on acquisition of Dinair Group AB

Vinge advises Madison Dearborn Partners on the recommended cash offer for Powerflute Oyj

Vinge advises Active Biotech on rights offering

Vinge advises Ventech in connection with investment in Freespee

Ventech is commencing an investment round of EUR 9.5 million in Freespee.

Vinge advises Smart Eye AB in conjunction with its listing on Nasdaq First North

Vinge has advised Smart Eye AB in connection with the listing of Smart Eye’s shares on Nasdaq First North.

Vinge advises Enfo in connection with the acquisition of e-man AB

Vinge has advised Enfo in connection with the acquisition of e-man AB.

Vinge has advised Avanza Bank in connection with the listing of its subordinated floating rate notes on Nasdaq Stockholm

Nasdaq Stockholm has approved Avanza Bank’s application for admission to trading of a subordinated floating rate note in the amount of SEK 100 million with a term of ten years.

Vinge has advised Svea Ekonomi i in connection with the listing of its tier 2 bond on Nasdaq Stockholm

Nasdaq Stockholm has approved Svea Ekonomi’s application for admission to trading of a Tier 2 bond in the amount of SEK 200 million with a term of ten years.

Vinge advises Medivir on its divestment of BioPhausia to Karo Pharma